Flu Shot Under Scrutiny: New Study Claims Higher Infection Risk, Sparks Controversy Over H3N2 Variant in China

Recent headlines have raised three questions that merit a clear, evidence‑based response:

1. Did a recent study find that the 2024‑2025 flu vaccine increased the risk of influenza among working‑aged adults?
2. Is the same vaccine linked to the emergence of a new H3N2 variant in China?
3. What should clinicians, public‑health officials, and the public do with this information?

Mass vaccinations are a scientific error as well as a medical error: The vaccination that is creating the variants – Prof. Luc Montagnier

In April 2020, Prof. Montagnier claimed that the alleged novel coronavirus was created in a lab. In 2021, the Nobel Prize winner from 2008 called the Covid vaccination program an “unacceptable mistake.” 

In this video, Prof. Luc Montagnier kept saying that he is doing his own experiments with those who become infected with the coronavirus after getting the vaccine. “I will show you that they are creating the variants that are resistant to the vaccine,” he said.

More And More Pandemics, Untill Mankind Submits

These globalists even threaten humanity with more suffering, if we don’t submit to their total control. Prince Charles joined DAVOS and publicly stated:

“There will be more and more pandemics, if we don’t do ‘The Great Reset’ now.”
Bill Gates already calls this ‘pandemic one’ and is talking about ‘pandemic two and three’.The investigator who back in 2013 predicted a coronavirus pandemic to occur in 2020, followed by riots, said the plan is to create series of pandemics during 2020-2030.

THE PLAN – WHO plans for 10 years of pandemics, from 2020 to 2030

The Pan American Health Organization (PAHO) and the World Health Organization (WHO) issued a briefing note on December 11, 2025, addressing the increasing circulation of the Influenza A(H3N2) subclade K (J.2.4.1) virus, which has become prominent in Europe and East Asia and shows signs of increased activity in the Americas. The rate of infection from this subclade has rapidly escalated, raising concerns for public health across the region.

1. Viral Evolution:
   • About the Influenza A(H3N2) subclade K is genetically linked to J.2.4 viruses but has developed several amino acid changes in the hemagglutinin protein.
   • In Europe, the activity of this subclade began earlier than usual, comprising nearly 50% of reported influenza cases from May to November 2025.

WHO’s deception:

A  study from the Cleveland Clinic presents alarming findings regarding the 2024-2025 flu vaccine. Conducted with over 53,000 participants, the research revealed that this year’s vaccination was linked to a higher risk of influenza among working-aged adults. This summary details the key findings and implications of the study for public health and vaccination strategies.

🚨NEW STUDY – Flu Vaccination Linked to 27% Increased Risk of Flu

📍 Major Cleveland Clinic study (n=53,402) finds −26.9% vaccine effectiveness during 2024–25 flu season.

📊 Adjusted analysis: Vaccinated had significantly higher flu incidence than unvaccinated (HR 1.27, p =… pic.twitter.com/C07p7o9bv9

— Nicolas Hulscher, MPH (@NicHulscher) April 7, 2025

• Ineffectiveness of Vaccination: The study indicated a vaccine effectiveness rate of -26.9%. This signifies that vaccinated individuals were at a higher risk of contracting influenza compared to those who were unvaccinated.
• Cumulative Incidence Rates: Initially, the cumulative incidence of influenza was nearly the same for both vaccinated and unvaccinated individuals. However, as the study progressed, the rate of influenza increased more quickly among those who had received the vaccine.
• Statistical Analysis: The analysis yielded a hazard ratio (HR) of 1.27, suggesting that vaccinated individuals experienced a 27% increased incidence of influenza compared to their unvaccinated counterparts.

It is essential for medical and public health officials to openly communicate these findings to patients to ensure informed decision-making regarding flu vaccinations.

The Cleveland Clinic’s study presents a critical re-evaluation of the flu vaccine’s effectiveness, indicating that the vaccine this season may significantly increase the risk of infection among working-aged adults.

April 2025: China boosts public health with massive vaccine and immunization progress

In China, flu vaccines for the 2025–2026 season (covering late 2025 into 2026) follow WHO recommendations and approvals from the National Medical Products Administration (NMPA). The approved and available types include:

• Trivalent Inactivated Influenza Vaccine (IIV3): Split-virus or subunit formulations, for ages 6 months and older.
• Quadrivalent Inactivated Influenza Vaccine (IIV4): Split-virus formulations, covering an additional B lineage (though B/Yamagata is no longer circulating globally), for ages 6 months and older.
• Trivalent Live Attenuated Influenza Vaccine (LAIV3): Nasal spray, for ages 3–17 years.

These vaccines update annually to match circulating strains, based on WHO’s February 2025 recommendations for the Northern Hemisphere. No specific brand names are universally mandated; availability varies by region and includes domestic producers (e.g., Sinovac’s Anflu® quadrivalent, Sinopharm/CNBG quadrivalent split virion) and possibly imported options. China’s CDC guidelines (2025–2026 edition) state no preference among types—any licensed vaccine is recommended for voluntary, often self-paid vaccination (free for certain groups like elderly in some provinces).

Side Effects:

• Soreness, redness, or swelling at the injection site (for inactivated vaccines).
• Low-grade fever, headache, muscle aches, fatigue, or nausea.
• For nasal spray (LAIV3): Runny nose, sore throat, or cough.

Serious side effects (e.g., severe allergic reactions like anaphylaxis or Guillain-Barré syndrome).

Ref:

1. Vaccination for Seasonal Influenza: https://www.drugoffice.gov.hk/eps/do/en/consumer/news_informations/dm_38.html
2. China CDC Influenza Vaccination Guidelines (2025–2026 references): https://www.chinacdc.cn/ (search for latest guidelines) or related updates: https://www.tropicalhainan.com/china-releases-updated-2025-2026-influenza-vaccination-guidelines/
3. WHO 2025–2026 Northern Hemisphere Composition: https://www.who.int/publications/m/item/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2025-2026-northern-hemisphere-influenza-season
4. Sinovac Influenza Vaccines: https://www.sinovac.com/en-us/portfolio/influenza
5. Sinopharm/CNBG Example: http://en.sinopharm.com/2025-04/23/c_20049.htm
6. General Side Effects (CDC/Mayo Clinic): https://www.cdc.gov/vaccine-safety/vaccines/flu.html or https://www.mayoclinic.org/drugs-supplements/influenza-virus-vaccine-intradermal-route-intramuscular-route/description/drg-20071452
7. https://qvive.in/india-news/bioweapon-covid-variants-discover-how-bill-gates-invests-in-a-lab-to-explore-the-possibility-of-developing-more-transmissive-and-fatal-variants/
8. Updates for the 2025-2026 Flu Season: https://www.cdc.gov/flu/season/2025-2026.html
9. End-of-Season Influenza Vaccine Effectiveness for the 2024/25 Season in Beijing, China. [ https://pmc.ncbi.nlm.nih.gov/articles/PMC12390381/ ]
10. What is the recommended composition of the 2025-26 seasonal influenza vaccine? [ https://www.chp.gov.hk/en/features/100764.html ]
11. What are trivalent and quadrivalent vaccines? Are they safe and effective? [https://www.chp.gov.hk/en/features/100764.html ]
12. What are the differences among inactivated influenza vaccine (IIV), recombinant influenza vaccine (RIV) and live attenuated influenza vaccine (LAIV)? [ https://www.chp.gov.hk/en/features/100764.html ]
13. Who should not receive live attenuated influenza vaccine (LAIV)? [ https://www.chp.gov.hk/en/features/100764.html ]
14. The 2024 Flu Vaccination in Beijing Begins. [ https://wjw.beijing.gov.cn/xwzx_20031/xwfb/202409/t20240912_3865291.html ]

Also Read: